Pulmonary Disease, Chronic Obstructive
Conditions
Brief summary
The purpose of this research study is to develop CT scanning and image analysis techniques to help define and measure several key properties of the pulmonary system that cannot be obtained by other tests or exams.
Detailed description
Specifically, the investigators are interested in understanding the difference between the normal aging process and the events that lead to emphysema. Additionally, the investigators are interested in understanding the earliest signs (lung inflammation) of the disease process leading to three lung diseases, which include emphysema, fibrosis and sarcoidosis; all of which are described as inflammatory lung diseases. The investigators will be using the data from this study to help define the normal values for the measured properties as well as deviation from normal values in smokers without defined lung disease and patients with inflammatory lung disease. The investigators believe that the analysis and scanning techniques being developed as part of this research will provide new and previously unavailable information on normal and diseased lungs so that ultimately the investigators can detect specific changes in the lungs due to a disease and measure any improvements in the anatomy and/or function of the pulmonary system after a patient has undergone treatment. This study involves research using X-Ray computed tomography (CT) scanner, which is similar to previous CT scanners but operates much faster and provides finer image detail.
Interventions
DIAGNOSTIC_TESTPulmonary Function Test
Spirometry, Diffusing Capacity of the Lungs (DLCO), Lung Volumes
DIAGNOSTIC_TESTCT Scans
volume scans, perfusion scan, ventilation scan
BEHAVIORALQuestionnaires
Human Subjects Questionnaire, Baseline Dyspnea Index, Chronic Respiratory Questionnaire
DIAGNOSTIC_TESTMRI
proton scans, hyperpolarized 3-Helium scan
BIOLOGICALXenon gas
ventilation CT scans
Sponsors
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Eric A. Hoffman
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
20 Years to 89 Years
Healthy volunteers
Yes
Inclusion criteria
* Non smokers, age 20-29, 40-49, 60-69, 80-89, cannot have smoked more than 20 cigarettes in their lifetime * Smokers, age 20-29, 40-49, 60-69, 80-89, currently smoking a minimum of 1 pack (20 cigarettes) per day, normal smokers and mild to moderate Chronic Obstructive Pulmonary Disease (COPD)
Exclusion criteria
* Allergies - no allergies to shellfish, eggs, iodine * Medications - no medications (except for birth control) for in the 'normal' category * No asthma - as self reported * BMI (Body Mass Index) - must not exceed 32 or 100kg of weight * No other radiology studies in the last 12 months * No metal in lung field - no metal from larynx to stomach * No known heart disease * No known kidney disease or diabetes * Must not be pregnant - subjects of childbearing potential with be given a urine pregnancy test
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Normal lung aging assessed by CT imaging | up to 10 years | Normal aging process of the lungs compared to common smoking related lung diseases. |
Countries
United States
Outcome results
None listed